openPR Logo
Press release

Pharmacovigilance (PV) Market is anticipated to grow further up to USD 18.4 billion by 2032 | IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical

06-15-2023 02:57 PM CET | Health & Medicine

Press release from: Global Insight Services

Pharmacovigilance (PV) Market

Pharmacovigilance (PV) Market

The global Pharmacovigilance Market was valued at 6.4 billion in 2022 and it is anticipated to grow up to USD 18.4 billion by 2032, at a CAGR of 11.1% during the forecast period.

Pharmacovigilance is the science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. Passive surveillance is the most common type of pharmacovigilance activity. It is important because it can identify previously unknown adverse events. However, it has some limitations, such as under-reporting and reporting bias. Active surveillance is less common, but it is useful for monitoring drugs that are used to treat rare conditions. Experimental studies are the most reliable way to assess the safety of a new medicine, but they are usually only conducted during the development and approval process. Pharmacovigilance is a complex and ever-changing field. It requires close collaboration between healthcare professionals, patients and the pharmaceutical industry.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS22087

Market Trends and Drivers

The key drivers of pharmacovigilance (PV) market are the increasing number of clinical trials, the growing prevalence of chronic and life-threatening diseases, and the need for better patient safety.

The number of clinical trials has been increasing over the years as the pharmaceutical industry seeks to develop new and better treatments for various diseases. This has led to an increase in the number of patients being exposed to new drugs, which has in turn led to an increase in the need for PV.

The prevalence of chronic and life-threatening diseases is also a key driver of the PV market. As the population ages, the number of people suffering from chronic diseases such as cancer and heart disease is increasing. This is leading to a greater need for PV, as these patients are often taking multiple medications that need to be closely monitored for safety.

Market Restraints and Challenges

The key restraints and challenges in Pharmacovigilance (PV) market include the following:

Lack of awareness of PV among patients and healthcare professionals: There is a lack of awareness of PV among patients and healthcare professionals. This is a challenge because it can lead to underreporting of adverse events and lack of data for safety monitoring.
Lack of standardization: There is lack of standardization in PV, which is a challenge because it can lead to inconsistency in data collection and analysis.
Limited resources: PV requires significant resources, which can be a challenge for many organizations.

Read Full Research Report : https://www.globalinsightservices.com/reports/pharmacovigilance-pv-market

Global Pharmacovigilance Market Segmentation

By Clinical Trial Phase

• Preclinical
• Phase I
• Phase II
• Phase III
• Phase IV

Major Players in the Global Pharmacovigilance Market

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Pharmacovigilance market include Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, IQVIA among others.

Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS22087

Reasons to buy Pharmacovigilance (PV) Market Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance (PV) Market is anticipated to grow further up to USD 18.4 billion by 2032 | IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical here

News-ID: 3090711 • Views:

More Releases from Global Insight Services

Dna Test Kits Market Is Anticipated To Expand From $2.8 Billion In 2024 To $13.1 Billion By 2034
Dna Test Kits Market Is Anticipated To Expand From $2.8 Billion In 2024 To $13.1 …
Market Overview The DNA Test Kits Market has emerged as one of the most dynamic sectors in the healthcare and consumer wellness industries. These kits allow individuals to gain valuable insights into their ancestry, health predispositions, and lifestyle traits by simply submitting a saliva sample. The convenience of at-home testing, combined with digital platforms for data interpretation, has made genetic information more accessible than ever before. The rising interest in personalized
Extended Reality Market Is Anticipated To Expand From $48.2 Billion In 2024 To $450 Billion By 2034
Extended Reality Market Is Anticipated To Expand From $48.2 Billion In 2024 To $ …
Market Overview The Extended Reality Market is rapidly evolving as organizations and consumers alike embrace immersive technologies. Extended reality (XR) is an umbrella term that combines virtual reality (VR), augmented reality (AR), and mixed reality (MR), offering users engaging digital experiences that bridge the physical and virtual worlds. With applications ranging from gaming and entertainment to healthcare, education, and industrial training, XR has become a catalyst for digital transformation. The growing
Building Information Modeling Market to Surpass $35.2 Bn by 2034 at 9% CAGR
Building Information Modeling Market to Surpass $35.2 Bn by 2034 at 9% CAGR
Market Overview Building Information Modeling Market is undergoing rapid transformation as digital construction technologies redefine the way projects are designed, built, and managed. BIM offers a comprehensive digital representation of physical and functional characteristics of buildings, enabling architects, engineers, and contractors to collaborate more effectively. This collaborative approach minimizes costly errors, enhances resource optimization, and improves overall project efficiency. Governments and private firms alike are recognizing BIM as an essential tool
Connected Healthcare Market to Reach $297.5 Bn by 2034, Growing at 13.3% CAGR
Connected Healthcare Market to Reach $297.5 Bn by 2034, Growing at 13.3% CAGR
Market Overview Connected Healthcare Market is rapidly transforming the way medical services are delivered, managed, and experienced. By integrating technologies such as telemedicine, wearable devices, mobile health apps, and cloud-based platforms, connected healthcare empowers patients and providers with seamless communication and real-time data access. This digital shift is not only improving patient outcomes but also reducing the strain on traditional healthcare systems. With a strong emphasis on efficiency, personalization, and accessibility,

All 5 Releases


More Releases for Pharmacovigilance

Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379 The List of Companies • #Accentures • Bristol-Myers Squibb Company • Linical Accelovance • Cognizant • Covance Inc. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline plc. • ICON plc • Capgemini (IGATE Corporation) Clinical
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market? The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications. Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776 Increasing cases of adverse drug reactions
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before